Lista de obras - Jean Clairambault - Dominio Público Uruguay

A Mathematical Model of the Cell Cycle and Its Circadian Control

A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery

artículo científico publicado en 2011

A spatial physiological model for p53 intracellular dynamics.

artículo científico publicado en 2012

A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation

artículo científico publicado en 2008

Adaptive dynamics of hematopoietic stem cells and their supporting stroma: a model and mathematical analysis

artículo científico publicado en 2019

Age-structured cell population model to study the influence of growth factors on cell cycle dynamics.

artículo científico publicado en 2013

An age-and-cyclin-structured cell population model for healthy and tumoral tissues.

artículo científico publicado en 2007

An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age structured equations

Analysis of a molecular structured population model with possible polynomial growth for the cell division cycle

Applying ecological and evolutionary theory to cancer: a long and winding road ⬇️

artículo científico publicado en 2012

Can theorems help treat cancer? ⬇️

artículo científico publicado el 19 de febrero de 2012

Cell plasticity in cancer cell populations

artículo científico publicado en 2020

Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation

artículo científico publicado en 2016

Circadian rhythm and tumour growth

Circadian timing in cancer treatments.

artículo científico publicado en 2010

Commitment of Mathematicians in Medicine: A Personal Experience, and Generalisations ⬇️

artículo científico publicado el 28 de octubre de 2011

Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues.

artículo científico publicado en 2018

Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors

scientific article published on 01 October 1996

Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation

artículo científico publicado en 2015

Enabling multiscale modeling in systems medicine

artículo científico publicado en 2014

Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.

artículo científico publicado en 2016

Heart rate variability in normal sleeping full-term and preterm neonates

artículo científico publicado el 1 de febrero de 1992

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma

scientific article published on 06 January 2020

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics

artículo científico publicado en 2008

Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 2: from Theoretical Biology to Mathematical Models

artículo científico publicado en 2017

Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer. Part 1: Biological Facts and Studies in Drug Resistance

artículo científico publicado en 2017

Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.

artículo científico publicado en 2007

Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors.

artículo científico publicado en 2014

Modelling targets for anticancer drug control optimization in physiologically structured cell population models

Modelling the genesis and treatment of cancer: the potential role of physiologically based pharmacodynamics.

artículo científico publicado en 2010

Myocardial determinants in regulation of the heart rate ⬇️

artículo científico publicado el 1 de noviembre de 1997

Optimizing cancer pharmacotherapeutics using mathematical modeling and a systems biology approach

artículo científico publicado en 2011

Period shift induction by intermittent stimulation in a Drosophila model of PER protein oscillations.

artículo científico publicado en 2000

Physiologically based mathematical models to optimize therapies against metastatic colorectal cancer: a mini-review

artículo científico

Physiologically based modelling of circadian control on cell proliferation

artículo científico publicado en 2006

Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies

Reaction-diffusion systems for spatio-temporal intracellular protein networks: A beginner's guide with two examples

artículo científico publicado en 2014

Rhythms from seconds to days. Physiological importance and therapeutic implications

artículo científico publicado en 2007

Rhythms from seconds to days: part 2. Cell proliferation

artículo científico publicado en 2008

Stepping From Modeling Cancer Plasticity to the Philosophy of Cancer

scientific article published on 19 November 2020

The dynamics of p53 in single cells: physiologically based ODE and reaction-diffusion PDE models

artículo científico publicado en 2014

The first international workshop on the role and impact of mathematics in medicine: A collective account.

artículo científico publicado en 2011

The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate

artículo científico publicado en 2013

Toxicity and anti-tumour efficacy of oxaliplatin on Glasgow osteosarcoma induced in mice: a mathematical model

artículo científico publicado en 2003

Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations

artículo científico publicado en 2016

Lista de obras de Jean Clairambault

A Mathematical Model of the Cell Cycle and Its Circadian Control

A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery

A spatial physiological model for p53 intracellular dynamics.

A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation

Adaptive dynamics of hematopoietic stem cells and their supporting stroma: a model and mathematical analysis

Age-structured cell population model to study the influence of growth factors on cell cycle dynamics.

An age-and-cyclin-structured cell population model for healthy and tumoral tissues.

An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age structured equations

Analysis of a molecular structured population model with possible polynomial growth for the cell division cycle

Applying ecological and evolutionary theory to cancer: a long and winding road ⬇️

Can theorems help treat cancer? ⬇️

Cell plasticity in cancer cell populations

Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation

Circadian rhythm and tumour growth

Circadian timing in cancer treatments.

Commitment of Mathematicians in Medicine: A Personal Experience, and Generalisations ⬇️

Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues.

Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors

Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation

Enabling multiscale modeling in systems medicine

Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.

Heart rate variability in normal sleeping full-term and preterm neonates

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics

Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 2: from Theoretical Biology to Mathematical Models

Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer. Part 1: Biological Facts and Studies in Drug Resistance

Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.

Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors.

Modelling targets for anticancer drug control optimization in physiologically structured cell population models

Modelling the genesis and treatment of cancer: the potential role of physiologically based pharmacodynamics.

Myocardial determinants in regulation of the heart rate ⬇️

Optimizing cancer pharmacotherapeutics using mathematical modeling and a systems biology approach

Period shift induction by intermittent stimulation in a Drosophila model of PER protein oscillations.

Physiologically based mathematical models to optimize therapies against metastatic colorectal cancer: a mini-review

Physiologically based modelling of circadian control on cell proliferation

Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies

Reaction-diffusion systems for spatio-temporal intracellular protein networks: A beginner's guide with two examples

Rhythms from seconds to days. Physiological importance and therapeutic implications

Rhythms from seconds to days: part 2. Cell proliferation

Stepping From Modeling Cancer Plasticity to the Philosophy of Cancer

The dynamics of p53 in single cells: physiologically based ODE and reaction-diffusion PDE models

The first international workshop on the role and impact of mathematics in medicine: A collective account.

The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate

Toxicity and anti-tumour efficacy of oxaliplatin on Glasgow osteosarcoma induced in mice: a mathematical model

Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations